A PHASE III MULTICENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY, PARALLEL-GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB COMPARED WITH TERIFLUNOMIDE IN ADULT PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

Public Engagement
Phase III Clinical Trial in RRMS

Dati Generali

Tipo

03 - Tematica relativa alle scienze della vita e salute

Strutture collegate

Ricerca

Settori


Goal 3: Good health and well-being

Parole chiave libere (3)

BTK INHIBITOR
FENEBRUTINIB
MULTIPLE SCLEROSIS
No Results Found

Afferenze

Referenti

TOMASSINI VALENTINA (Organizzatore, Partecipante)

Partecipanti

TOMASSINI VALENTINA (Organizzatore, Partecipante)